Comparison of the epidemiological characteristics of neural tube defects classified according to failure of the different points of closure;Comparación de las características epidemiológicas de los defectos del tubo neural clasificados según el fallo de los distintos puntos de cierre

Anales Espanoles de Pediatria

Volumn 57, Issue 5, 2002, Pages 457-465

  Sanchis Calvo A ^a   Martinez Frias Ma L ^b  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Epidemiology of the multi site closure failure of the neural tube; Neural tube defects

Indexed keywords

VALPROIC ACID;

ABORTION; ARTICLE; COMPARATIVE STUDY; DATA ANALYSIS; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MATERNAL DIABETES MELLITUS; NEURAL TUBE DEFECT; NEWBORN; POPULATION RESEARCH; PRENATAL DIAGNOSIS; RECURRENT DISEASE; SPAIN; TREATMENT FAILURE; WOUND CLOSURE;

HUMANS; NEURAL TUBE DEFECTS; RISK FACTORS;

EID: 0036872731     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Golden JA, Chernoff GF. Anterior neural tube closure in the mouse: Fuel for disagreement with the classical theory. Clinical Research 1983;31:127A.
2. Van Allen MI, Kalousek DK, Chernoff GF, Juriloff D, Harris M, McGillivray BC, et al. Evidence for multi-site closure of the neural tube in humans. Am J Med Genet 1993;47:723-43.
3. Sanchís Calvo A, Martínez-Frías ML. Estudio clínico epidemiológico de los defectos del tubo neural clasificados por los cincos puntos del mismo. An Esp Pediatr 2001;54:165-73.
4. Juriloff DM, Harris MJ. Mouse models for neural tube closure defects. Human Mol Gen 2000;9:993-1000.
5. Nakatsu T, Uwabe Ch, Shiota K. Neural tube closure in humans initiates at multiple sites: Evidence from human embryos and implications for the pathogenesis of neural tube defects. Anat Embryol 2000;201:455-66.
6. Martinez-Frias ML, Urioste M, Bermejo E, Sanchis A, Rodriguez Pinilla E. Epidemiological analysis of multi-site closure failure of neural tube in himans. Am J Med Genet 1996;66:64-8.
7. Martinez-Frias ML, Sanchis A, Aparicio P, Blanco M, Garcia MJ, Gomez-Ullate J, et al. Description of the characteristic of cases with non contiguous neural tube defects identified in a series of consecutive births. Teratology 1998;57:13-6.
8. Martínez Frías ML. Manual operacional. Madrid: ECEMC, 1995.
9. Catálogo de Especialidades Farmacéuticas 1997. Edita Consejo General de Colegios Oficiales de Farmacéuticos. ISBN: 84-87276-30-X.
10. Hall JG, Friedman JM, Kenna BA, Popkin J, Jawanda M, Arnold W. Clinical, genetic and epidemiological factors in neural tube defects. Am J Hum Genet 1988;43:827-37.
11. Shaw GM, Jensvold NG, Wasserman CR, Lammer EJ. Epidemiologic characteristics of phenotipically distinct neural tube defcts among 0.7 million California births, 1983-1987. Teratology 1994;49:143-9.
12. Elwood JM, Little J, Elwood JH. Epidemiology and control of neural tube defects. Oxford: Oxford University Press, 1994: p. 306-23.
13. MRC (Medical Research Council) Vitamin study research group. Prevention of neural tube defects: Results of the Medical Research Council Vitamin study. Lancet 1991;338:131-7.
14. Czeizel AE, Dudas I. Prevention of the first ocurrence of neural tube defects by periconceptional vitamine supplementation. N Engl J Med 1992;327:1832-5.
15. Ou CY, Stevenson RE, Bronw VK, Schwartz CE, Allen WP, Khoury Mj, et al. 5,10-methylenetetrahidrofolate reductase genetic polimorphisme as a risk factor for neural tube defects. Am J Med Genet 1996;63:610-4.
16. Volcik KA, Blanton SH, Tyerman GH, Jong ST, Page TZ, Romaine NK, et al. Methylenetetrahydrofolate reductase and spina bifida: Evaluation of level of defect and maternal gennotypic risk in Hispanics 2000;95:21-7.
17. Koch MC, Stegmann K, Ziegler A, Schröter B, Ermet A. Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population. Eur J Pediatr 1998;157: 487-92.
18. De Franchis R, Buonincnti A, Mandato C, Pepe A, Sperandeo MP, Del Gado R, et al. The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy. J Med Genet 1998;35:100-13.
19. Berry RJ, Zhu Li MP, Erickson JD, Song Li DDS, Moore CA, Hong Wang, et al. Prevention of neural tube defects with folic acid in China. N Engl J Med 1999;341:1485-90.
20. O'Rahilly R, Müller F. Bidirectional closure of the rostral neuropore in the human embryo. Am J Anat 1989;184:259-68.
21. Martínez Frías ML, Prieto L, Bermejo E, Gaya F. Estudio del peso al nacimiento sobre una población de niños sin defectos congénitos I. Curvas de percentiles de peso por edad gestacional. An Esp Pediatr 1990;33:12-5.
22. Umbral'94. Estudio epidemiológico nacional sobre las patologías neonatales. AEP 1994.
23. Jordaan HVF. Newborn brain: Body weigth ratios. Am J Phys Anthropol 1976;44:279-84.
24. Martinez Frias MI, Parralo JA, Salvador J, Frías JL. Sex ratios in neural tube defects. Lancet 1986;i:871-2.
25. Seller MJ. Neural tube defects and sex ratios. Am J Med Genet 1987;26:699-707.
26. Mariman EC, Hamel BC. Sex ratios of affected and transmitting members of multiple case families with neural tube defects. J Med Genet 1992;29:695-8.
27. Van Allen MI. Multisite neural tube closure in humans. Birth Defects 1996;30:203-25.
28. Seller MJ. Sex, neural tube defects and multisite closure of the human neural tube. Am J Med Genet 1995;58:332-6.
29. Costra RJ, Baljet B, Hennekan RC. Congenital anomalies in the teratological collection of Museum Vrolik in Amsterdam, The Netherlans. IV: Closure defects of the neural tube. Am J Med Genet 1998;80:60-73.
30. Khoury MJ, Erickson JD, James LM. Etiologic heterogeneity of neural tube defects: Clues from epidemiology. Am J Epidemiol 1982;115:538-48.
31. Martínez Frías ML, Frías JL. Are blastogenetic anomalies sporadic? Am J Med Genet 1997;68:381-7.
32. Byrne J, Cama A, Vigliarolo M, Levato L. Patterns of inheritance in Irish and Italien families with neural tube defects: Comparison between high and low rate areas. Ir Med J 1997;90:32-4.
33. Hunter AGW, Cleveland RH, Blickman JG, Holmes LB. A study of level, associated malformations and sib ocurrence risks in spine bifida. Teratology 1996;54:213-8.
34. Blatter BM, Lafebre AB, Peters PW, Roeleved N, Verbeek AL, Gabreels FJ. Heterogeneity of spina bifida. Teratology 1997;55:224-30.
35. Papp C, Adam Z, Thót-Pál E, Török O, Varadi V, Papp Z. Risk of recurrence of craniospinal anomalies. J Matern Fetal Med 1997;6:53-7.
36. Little J. Risks in siblings and other relatives. En: Elwood JM, Little J, Elwood JH, editors. Epidemiology and control neural tube defects. Oxford: Oxford University Press, 1992: p. 456-520.
37. Wang Y, Wu Y, Zhou G, Xu C, Xiao K. An estimate of recurrence risk for neural tube defects in China. Hua Hsi Y Ko Ta Hsueh Hsueh Pao 1996;27:196-8.
38. Martinez Frias ML. Epidemilogical analysis of outcomes of pregnancy in the diabetics mothers: Identification of the most characteristic and most frequent congenital anomalies. Am J Med Genet 1994;51:108-13.